Focal Therapy and Oncology: State of Play in 2021
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 5930
Special Issue Editor
Interests: cancer; photodynamic therapy; apoptosis; cyclooxygenase-2
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, “Focal therapy and oncology: state of play in 2021”, will cover a selection of recent research topics and current review articles related to the intracellular signaling of resistance to apoptosis in cancer. Up-to-date review articles, commentaries and experimental papers are all welcome.
Despite medical research advances in anti-cancer treatments, many side effects persist in patients, as well as development of resistances to conventional treatments. The development of new anti-cancer therapeutic strategies is necessary in order to improve care of patients. Focal therapies, such as photodynamic therapy using photosensitizers, come as an innovative therapeutic strategy that severely restricts these undesirable side effects. Photodynamic therapy has been approved for the treatment of some cancers due to the generation of cytotoxic reactive oxygen species only with photoactivated photosensitizers.
It has been shown that cancer cells escape the apoptotic phenomenon, allowing them to grow uncontrollably. Apoptosis in anti-cancer PDT is mostly induced by its intrinsic pathway. The apoptotic process is subject to numerous regulations that can lead to resistance mechanisms. These resistances are often responsible for the ineffectiveness of certain anti-cancer therapies, underlining the growing interest in interest in combination therapies.
Prof. Dr. Bertrand Liagre
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- apoptosis
- focal therapy
- new treatment
- clinical trials
